Skip to main content
SpringerLink
Log in

The Problems of Childhood Obesity and the Metabolic Syndrome

  • Chapter
Overweight and the Metabolic Syndrome

Part of the book series: Endocrine Updates ((ENDO,volume 26))

  • 831 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 2002;288:1728–1732.

    Article  PubMed  Google Scholar 

  2. National Center of Health Statistics: NHANES III Reference Manuals and Reports. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1996.

    Google Scholar 

  3. Center for Disease Control and Prevention. Prevalence of overweight among adolescents, 1988–1991. MMWR 1994;43:818–821.

    Google Scholar 

  4. Wang G, Dietz WH. Economic burden of obesity in youth aged 6–17 years: 1979–1999. Pediatrics 2002;109:E81–E82.

    Article  PubMed  Google Scholar 

  5. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346(11):802–810.

    Article  PubMed  CAS  Google Scholar 

  6. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350(23):2362–2374.

    Article  PubMed  CAS  Google Scholar 

  7. Dietz WH. Health consequences of obesity in youth: Childhood predictors of adulthood disease. Pediatrics 1998;101(Suppl 3):518–525.

    PubMed  CAS  Google Scholar 

  8. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998;338:1650–1656.

    Article  PubMed  CAS  Google Scholar 

  9. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988;37(12):1595–1607.

    PubMed  CAS  Google Scholar 

  10. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24(4):683–689.

    PubMed  CAS  Google Scholar 

  11. Levitt NS, Lambert EV. The foetal origins of the metabolic syndrome—a South African perspective. Cardiovasc J S Afr 2002;13(4):179–180.

    PubMed  Google Scholar 

  12. Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab 2002;13(9):368–373.

    Article  PubMed  CAS  Google Scholar 

  13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–553.

    Article  PubMed  CAS  Google Scholar 

  14. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 01-3670. Bethesda, MD: National Institutes of Health, 2001.

    Google Scholar 

  15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination survey. JAMA 2002;287:356–359.

    Article  PubMed  Google Scholar 

  16. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 2004;27(10):2444–2449.

    PubMed  Google Scholar 

  17. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345–354.

    PubMed  CAS  Google Scholar 

  18. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. An American Heart Association Scientific Statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003;107:1448.

    Article  PubMed  Google Scholar 

  19. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003;157(8):821–827.

    Article  PubMed  Google Scholar 

  20. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004;89(1):108–113.

    Article  PubMed  CAS  Google Scholar 

  21. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1673–1808.

    Article  CAS  Google Scholar 

  22. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785–1788.

    Article  PubMed  CAS  Google Scholar 

  23. Rajala MW, Scherer PE. The adipocyte at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 2003:3765–3773.

    Google Scholar 

  24. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann NY Acad Sci 2000;146-154.

    Google Scholar 

  25. Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148;209–214.

    Article  PubMed  CAS  Google Scholar 

  26. Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia 1998,41:1241–1248.

    Article  PubMed  CAS  Google Scholar 

  27. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99(2):237–242.

    PubMed  CAS  Google Scholar 

  28. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336(14):973–979.

    Article  PubMed  CAS  Google Scholar 

  29. Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance. Diabetes Care 2003;26(8):2323–2328.

    PubMed  CAS  Google Scholar 

  30. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003;108(24):2993–2999.

    Article  PubMed  CAS  Google Scholar 

  31. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004;109(17):2046–2049.

    Article  PubMed  CAS  Google Scholar 

  32. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005;111(6):747–753.

    Article  PubMed  CAS  Google Scholar 

  33. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345–354.

    PubMed  CAS  Google Scholar 

  34. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003;290(14):1884–1890.

    Article  PubMed  CAS  Google Scholar 

  35. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin North Am 1999;28:709–729.

    Article  PubMed  CAS  Google Scholar 

  36. Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15(Suppl 1):509–517.

    PubMed  Google Scholar 

  37. Polonsky KS, Sturis J, Bell GI. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus—a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996;334:777–783.

    Article  PubMed  CAS  Google Scholar 

  38. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 1997;46:701–710.

    PubMed  CAS  Google Scholar 

  39. Knowler WC, Barrett-Connor E, Fowler SE, et al. and Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.

    Article  PubMed  CAS  Google Scholar 

  40. Tuomilehto J, Lindstrom J, Eriksson JG, and Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343–1350.

    Article  PubMed  CAS  Google Scholar 

  41. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346(11):802–810.

    Article  PubMed  CAS  Google Scholar 

  42. Keamseng C, Likitmaksul S, Kiattisakthavee P, et al. Risk of metabolic disturbance and diabetes development in Thai obese children, 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes, Saint-Malo, France, September 3–6, 2003.

    Google Scholar 

  43. Lee W, Tang J, Karim H, et al. Abnormalities of glucose tolerance in severely obese Singapore children, 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes, Saint-Malo, France, September 3–6, 2003.

    Google Scholar 

  44. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004;89(1):108–113.

    Article  PubMed  CAS  Google Scholar 

  45. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study. Lancet 2001;358:1400–1404.

    Article  PubMed  CAS  Google Scholar 

  46. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104(6):787–794.

    Article  PubMed  CAS  Google Scholar 

  47. Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: A syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362(9388):951–957.

    Article  PubMed  CAS  Google Scholar 

  48. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr 2002;22:325–346.

    Article  PubMed  CAS  Google Scholar 

  49. Krssak M, Falk Petersen K, Dresner A, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 1999;42:113–116.

    Article  PubMed  CAS  Google Scholar 

  50. Boesch C, Kreis R. Observation of intramyocellular lipids by 1H-magnetic resonance spectroscopy. Ann NY Acad Sci 2000;904:25–31.

    Article  PubMed  CAS  Google Scholar 

  51. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: Validation in vivo. Am J Physiol 1999;276(5 Pt 1):E977–E989.

    PubMed  CAS  Google Scholar 

  52. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;109(10):1345–1350.

    Article  PubMed  CAS  Google Scholar 

  53. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 2000;275:8456–8460.

    Article  PubMed  CAS  Google Scholar 

  54. Bays H, Mandarino L, Defronzo R. Role of adipocyte, free fatty acids and ectopic fat in the pathogenesis of type 2 diabetes mellitus: Peroximal proliferator-activated receptoragonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004,89(2):463–478.

    Article  PubMed  CAS  Google Scholar 

  55. Kahn ES. The importance of beta cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86(9):4047–4058.

    Article  PubMed  CAS  Google Scholar 

  56. Ahren B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004;150(2):97–104.

    Article  PubMed  CAS  Google Scholar 

  57. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. Beta cell function across the spectrum of glucose tolerance in obese youth. Diabetes (in press).

    Google Scholar 

  58. Bonadonna RC, Stumvoll M, Fritsche A, et al. Altered homeostatic adaptation of first-and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: Studies with a minimal model to assess beta-cell function. Diabetes 2003;52(2):470–480.

    PubMed  CAS  Google Scholar 

  59. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 1997;46:701–710.

    PubMed  CAS  Google Scholar 

  60. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988;319:1500–1506.

    Article  PubMed  CAS  Google Scholar 

  61. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28(4):902–909.

    PubMed  Google Scholar 

  62. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R; Baltimore Longitudinal Study of Aging. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003;52(6):1475–1484.

    PubMed  CAS  Google Scholar 

  63. Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diabetes Care 1998;21(7):1183–1187.

    PubMed  CAS  Google Scholar 

  64. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and the Children’s General Clinical Research Center, Yale University School of Medicine, New Haven, CT, 06520, USA

    Sonia Caprio & Ram Weiss

Authors
  1. Sonia Caprio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ram Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA, USA

    George A. Bray MD  & Donna H. Ryan MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Caprio, S., Weiss, R. (2006). The Problems of Childhood Obesity and the Metabolic Syndrome. In: Bray, G.A., Ryan, D.H. (eds) Overweight and the Metabolic Syndrome. Endocrine Updates, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-32164-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-32164-6_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-32163-9

  • Online ISBN: 978-0-387-32164-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation